Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
the retention of several DNA damage response proteins in foci that form around DSBs
3-benzoxazol-2-one
CAS Number: 923359-38-0
In treated osteosarcoma cells
PubMed PMID: 22388233
Oclacitinib - CAS# 1208319-26-9 Catalog No.:M9848-2 the retention of several DNAOclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nM and did not inhibit a panel of 38 non JAK kinases (IC50 's > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1 dependent cytokines involved in allergy and
US$ 20.00
US$ 16.80
US$ 20.10
US$ 10.00
US$ 50.00
US$ 67.00
US$ 25.50
US$ 29.00
US$ 40.00
US$ 85.00